Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment
about
Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaeditRecent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparumSpread of artemisinin resistance in Plasmodium falciparum malariaMalaria in the Greater Mekong Subregion: heterogeneity and complexityArtemisinin-resistant malaria: research challenges, opportunities, and public health implicationsNew Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus MefloquineArtemisinin Resistance in Plasmodium falciparum MalariaGametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian childrenMefloquine for preventing malaria in pregnant womenEmergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyMefloquine safety and tolerability in pregnancy: a systematic literature reviewThe counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidencePharmacokinetic and pharmacodynamic considerations in antimalarial dose optimizationCholine analogues in malaria chemotherapyOpen Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos ArylpyrrolesAnalogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivoGlucose-6-phosphate dehydrogenase-6-phosphogluconolactonase: a unique bifunctional enzyme from Plasmodium falciparumGametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient dataDiscovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reducesGeographic structuring of the Plasmodium falciparum sarco(endo)plasmic reticulum Ca2+ ATPase (PfSERCA) gene diversityAn open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in AsiaDeclining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coastIn vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genesImproving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugsNonlinear mixed-effects modelling of in vitro drug susceptibility and molecular correlates of multidrug resistant Plasmodium falciparumThe Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line TherapiesMolecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studiesTotal synthesis of thiaplakortone a: derivatives as metabolically stable leads for the treatment of malaria.Experimental evolution of resistance to artemisinin combination therapy results in amplification of the mdr1 gene in a rodent malaria parasite.The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children.Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border.Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial.Laboratory detection of artemisinin-resistant Plasmodium falciparumUse of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal.Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa.Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription.2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes.Artemisinin‐induced dormancy in plasmodium falciparum: duration, recovery rates, and implications in treatment failure.Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.
P2860
Q21032449-E218129A-49B2-40D1-9740-9EF2EA8AFD16Q21032477-77A97E38-1CDE-468C-A467-367C50CCD797Q21032481-C300EA6F-CA30-450B-A945-C62465338888Q21032492-2AE8B1C4-9156-4E1C-962A-1D4AFD75269FQ21032532-E9240A31-BB2B-4927-90B2-B73A5553D22BQ22061804-45A198B8-08F4-47FD-8671-30E76E2C2899Q22061852-34E78E62-CDF7-4F08-8328-0E9915A21FFFQ22773191-E31F0D0E-8960-44DC-9FD5-C68F89BA06EEQ24186956-3975B6FF-0084-4344-B2EC-DAC7081B932CQ24598695-C7E8A22A-734F-4A43-B220-4966B259601CQ24599164-214668DB-EC30-439F-82D5-E8312C060A06Q26828002-15BF3DCC-B044-435D-9E22-2362CF55F0A9Q26830528-CCF2DAA8-18FF-4550-93F8-69538A7BB110Q26851323-C1CB4D88-C873-4EF2-852B-DD61B4C44924Q26883657-0281A6D1-0F29-4583-8A11-FF7B9E58FE17Q27861933-2E43519A-0A94-4AF0-AB7B-EEECC7A1202CQ27974087-2EBF2A70-46B7-427D-9AC0-15D6EE91ACC2Q28068072-C851E8BF-8363-4B1F-A727-09083E8B9F89Q28271436-844F9DA8-E022-4594-8E16-DFE7E7005C72Q28473014-F438BDDA-013D-49C5-80DA-C3E6D4F034C6Q28474978-ED9B8862-693F-4D0D-8C1C-28466CD06FB7Q28477892-99DED2D4-3FC8-464C-8E8A-33B33726DAE4Q28484068-00F2E8FB-C882-41C8-BA9B-3E37C86B53CDQ28534701-2F2C7CC2-7C0A-47B2-A339-6E7DA7443C37Q28534820-CA955794-B652-41FE-8833-6095D06847E1Q28551049-12EABA3B-6C1D-43F7-8A7E-999F2EE341EBQ30568502-94284B16-6A56-448E-92DD-14BAFEE3423BQ33636433-8115AFC5-CFC8-47AA-BB46-C735377A627BQ33640021-9F6A50AF-D06C-4EF8-B8CA-8DD0149D27B3Q33655603-072D0EA4-D481-4EFA-88E4-7ACC2B19BD51Q33711891-7D4EB161-A899-40A7-A33E-C9CD05596DC4Q33754684-341B18ED-4946-498A-8AE6-6ECB33427C53Q33772980-0792E435-E3B7-4C6D-9BD7-0C76D717EBAEQ33798139-2D249003-1110-4CA3-A3C6-DA95DF7602F5Q33922076-80CFF58C-1730-4FEF-9F06-190049D53CFFQ33962907-22C525E3-EF80-40D4-B442-20A231DBB161Q33979085-29B18DA0-BC90-428D-9310-8AD3E1DF4C22Q34098128-6AAA5373-F35D-41A8-AC03-D46B6BCD9D23Q34172447-10DB759D-E0AA-42DA-A224-2B88B08D7ED9Q34221869-25755313-8CA1-4118-B589-BFFC92F49165
P2860
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Changes in the treatment respo ...... years of continuous deployment
@ast
Changes in the treatment respo ...... years of continuous deployment
@en
Changes in the treatment respo ...... years of continuous deployment
@en-gb
Changes in the treatment respo ...... years of continuous deployment
@nl
type
label
Changes in the treatment respo ...... years of continuous deployment
@ast
Changes in the treatment respo ...... years of continuous deployment
@en
Changes in the treatment respo ...... years of continuous deployment
@en-gb
Changes in the treatment respo ...... years of continuous deployment
@nl
prefLabel
Changes in the treatment respo ...... years of continuous deployment
@ast
Changes in the treatment respo ...... years of continuous deployment
@en
Changes in the treatment respo ...... years of continuous deployment
@en-gb
Changes in the treatment respo ...... years of continuous deployment
@nl
P2093
P2860
P50
P3181
P1433
P1476
Changes in the treatment respo ...... years of continuous deployment
@en
P2093
Alan Brockman
Elizabeth A Ashley
Lucy Phaiphun
Marion Barends
Michele van Vugt
Piyanuch Preechapornkul
Robert Hutagalung
Stephane Proux
Tim Anderson
P2860
P3181
P356
10.1371/JOURNAL.PONE.0004551
P407
P50
P577
2009-01-01T00:00:00Z